Table: Fuji Pharmaceutical - 6-MTH group results

Fuji Pharma

09/05/2024 09:00

May 9 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Sep 30, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             21.39               19.23            46.06    
                 (+11.2 pct)         (+8.5 pct)       (+12.6 pct) 
  Operating          1.44                1.82             3.99    
                 (-20.9 pct)         (-32.7 pct)      (+3.4 pct)  
  Recurring          2.17                2.46             4.60    
                 (-11.8 pct)         (-14.3 pct)      (+1.8 pct)  
  Net                4.26                1.77             6.19    
                (+140.2 pct)         (-3.3 pct)       (+80.0 pct) 
  EPS            175.15 yen           72.95 yen       254.51 yen  
  Ann Div                             37.00 yen        42.50 yen  
  -Q2 div         20.00 yen           17.00 yen                   
  -Q4 div                             20.00 yen        22.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T